Alaunos Therapeutics Statistics
Total Valuation
TCRT has a market cap or net worth of $4.63 million. The enterprise value is $1.51 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TCRT has 2.21 million shares outstanding. The number of shares has increased by 1.20% in one year.
Current Share Class | 2.21M |
Shares Outstanding | 2.21M |
Shares Change (YoY) | +1.20% |
Shares Change (QoQ) | +4.69% |
Owned by Insiders (%) | 4.70% |
Owned by Institutions (%) | 11.73% |
Float | 2.10M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 731.56 |
Forward PS | n/a |
PB Ratio | 1.07 |
P/TBV Ratio | 1.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 251.73 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.48
Current Ratio | 3.48 |
Quick Ratio | 2.68 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -107.45% and return on invested capital (ROIC) is -67.90%.
Return on Equity (ROE) | -107.45% |
Return on Assets (ROA) | -53.61% |
Return on Invested Capital (ROIC) | -67.90% |
Return on Capital Employed (ROCE) | -110.27% |
Revenue Per Employee | $6,000 |
Profits Per Employee | -$3.99M |
Employee Count | 1 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.00% in the last 52 weeks. The beta is -0.81, so TCRT's price volatility has been lower than the market average.
Beta (5Y) | -0.81 |
52-Week Price Change | -25.00% |
50-Day Moving Average | 3.35 |
200-Day Moving Average | 2.47 |
Relative Strength Index (RSI) | 38.86 |
Average Volume (20 Days) | 340,940 |
Short Selling Information
The latest short interest is 12,095, so 0.55% of the outstanding shares have been sold short.
Short Interest | 12,095 |
Short Previous Month | 27,542 |
Short % of Shares Out | 0.55% |
Short % of Float | 0.58% |
Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, TCRT had revenue of $6,000 and -$3.99 million in losses. Loss per share was -$2.46.
Revenue | 6,000 |
Gross Profit | -581,000 |
Operating Income | -4.04M |
Pretax Income | -26.77M |
Net Income | -3.99M |
EBITDA | -4.04M |
EBIT | -4.04M |
Loss Per Share | -$2.46 |
Full Income Statement Balance Sheet
The company has $2.88 million in cash and n/a in debt, giving a net cash position of $2.88 million or $1.31 per share.
Cash & Cash Equivalents | 2.88M |
Total Debt | n/a |
Net Cash | 2.88M |
Net Cash Per Share | $1.31 |
Equity (Book Value) | 3.66M |
Book Value Per Share | 1.76 |
Working Capital | 2.66M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -2.85M |
Capital Expenditures | n/a |
Free Cash Flow | -2.85M |
FCF Per Share | -$1.29 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -67,283.33% |
Pretax Margin | -66,550.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TCRT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.20% |
Shareholder Yield | -1.20% |
Earnings Yield | -90.97% |
FCF Yield | -64.84% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 18, 2024. It was a reverse split with a ratio of 1:10.
Last Split Date | Jul 18, 2024 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
TCRT has an Altman Z-Score of -272.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -272.53 |
Piotroski F-Score | 2 |